Dividends Calendar Earnings Calendar
EXEL

EXEL | Exelixis Inc

Healthcare sector
Exelixis Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Alameda, California, United States

Trade prices

  • Volume:
  • Market Cap: 6.92B
  • Prev closed:
  • Open: 20.99
  • High: 21.24
  • Low: 20.38
  • 52 week low: 15.5
  • 52 week high: 25.77
  • Dividends:No Dividends

Next ER: August 9, 2022 



Top Stories (EXEL)

    About the Company

    Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 2, 2022
    August 9, 20220.22 / 0.1936419.43M / 390.44MBeat!
    May 10, 20220.21 / 0.143355.98M / 374.45M
    February 17, 20220.29 / 0.0855451.14M / 355.78MBeat!
    November 2, 20210.12 / 0.1955328.4M / 358.58M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 9, 2022 21.06 21.71
    21.73
    20.97
    		 3.77M -2.27%
    Aug 8, 2022 21.55 21.75
    22.04
    21.20
    		 2.24M 0.14%
    Aug 5, 2022 21.52 21.35
    21.74
    21.00
    		 2.55M 0.37%
    Aug 4, 2022 21.44 21.33
    21.57
    21.21
    		 1.27M 0.19%
    Aug 3, 2022 21.40 21.69
    21.98
    21.38
    		 1.46M -0.42%
    Aug 2, 2022 21.49 20.92
    21.56
    20.80
    		 1.66M 2.53%
    Aug 1, 2022 20.96 20.95
    21.11
    20.76
    		 1.54M 0.19%
    Jul 29, 2022 20.92 21.50
    21.50
    20.65
    		 2.11M 0.92%
    Jul 28, 2022 20.73 21.34
    21.34
    20.31
    		 1.39M -2.63%
    Jul 27, 2022 21.29 21.29
    21.43
    20.98
    		 1.42M -0.19%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:15 November 1994, Cambridge, Massachusetts, United States
    • Employees:484

    News

    News for (EXEL)

    This company doesn't provide a dividend.


    Talk about Exelixis Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 9, 2022 (Same day)

    akam rl syy h armk emr dar cron save ingr tdg ions 


    Jump to (Finance sites)

    Google   
             

    Research 


    Investor page

    ir.exelixis.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 83
    HOLD 17
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.